Previous 10 | Next 10 |
Channelchek news releases related Channelchek news releases and Channelchek press releases from 08/13/21 12:00:00 on US and Canada Markets.
Over achieves Q2 expectations. Revenues increased a solid 18.4% to $49.3 million, beating our estimate of $44.8 million by 10%. Given tight expense controls, adjusted EBITDA was $4.4 million, an increase of over 800% from the year earlier, out performing our estimate by nearly 100%. Each opera...
2Q21. Revenue of $1.26 billion was up 29% year-over-year (26.2% in constant currency) driven by increased customer demand as the economy recovers and a 310 bp impact from Softworld. Kelly reported operating earnings of $13.7 million, up 24.1% y-o-y, and up 29.3% sequentially. GAAP EPS for 2Q21...
2Q21 Results. Revenue totaled $14.9 million, up 12% sequentially and 28% year-over-year. OSS reported GAAP EPS of $0.09 compared to $0.00 last year. Adjusted EPS for the second quarter of 2021 was $0.04, compared to $0.01 last year. Adjusted EBITDA rose to $1.4 million, up $1.3 million year-ov...
Onconova Reported 1Q21 and Updated Its Clinical Trial Progress Onconova reported a net loss of $4.2 million or $(0.27) per share for 2Q21, ended June 30. Cash on hand was $43.7 million, which we project to be sufficient for operations through 2023. The company gave updates on the clinical prog...
2Q21 Results. Revenue totaled $14.9 million, up 12% sequentially and 28% year-over-year. OSS reported GAAP EPS of $0.09 compared to $0.00 last year. Adjusted EPS for the second quarter of 2021 was $0.04, compared to $0.01 last year. Adjusted EBITDA rose to $1.4 million, up $1.3 million year-ov...
Significant Data Was Presented In 2Q21. PDS Biotechnology reported 2Q21 loss of $0.6 million or $(0.03) per share. Importantly, interim Phase 2 data from the lead trial for PDS0101 presented at the ASCO conference showed strong indications of efficacy. Additional data from this PDS0101 trial a...
Tight supply and higher container rates are positives for upcoming charters. Based on Contex indices, rates have continued to move up in 3Q2021 and term charters remain common. Our current EBITDA estimates assume that the Corfu/Evridiki/Astoria/Aegean Express feeders will soon secure longer te...
ATHENS, Greece, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Euroseas Ltd. (NASDAQ: ESEA, the “Company” or “Euroseas”), an owner and operator of container carrier vessels and provider of seaborne transportation for containerized cargoes, announced today its results for the thr...
Production is soaring due to the performance of recently drilled wells. InPlay reported average production of 5,380 boe/d in the June quarter, up 71% versus last year and above our forecast of 5,167 boe/d. The jump in production reflect strong performance by three Pembina wells drilled in the ...
Stock buy back program announced. The Board of Directors approved a stock buy back program of up to $17 million. At the current price, the buy back equals ~16.4 million shares, or close to 10% of the current shares outstanding of ~168.5 million. We believe that this positive move should help s...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
41.28%Change Percent:
Xponential Fitness Inc. Class A Company Name:
XPOF Stock Symbol:
NYSE Market:
xponential.com Website: